Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Diamond

Showing results (541-550 of 562) with videos related to

Pageof 57
Sort By:
The Lancet. Haematology|February 9, 2016
Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trialRyotaro Nakamura, Corinna La Rosa, Jeffrey Longmate, et al.
The Journal of Infectious Diseases|March 10, 2012
Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvantCorinna La Rosa, Jeff Longmate, Simon F Lacey, et al.
JAMA|October 10, 2023
A Multilevel Primary Care Intervention to Improve Follow-Up of Overdue Abnormal Cancer Screening Test Results: A Cluster Randomized Clinical TrialSteven J Atlas, Anna N A Tosteson, Adam Wright, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human PrimatesFlavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
Blood|July 2, 2011
Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic miceSimon F Lacey, Corinna La Rosa, Teodora Kaltcheva, et al.
NPJ Vaccines|January 22, 2022
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primatesFlavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
Blood Advances|January 10, 2022
Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunityHoda Pourhassan, Corinna La Rosa, Flavia Chiuppesi, et al.
Clinical and Vaccine Immunology : CVI|March 17, 2017
Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV TransmissionQihua Fan, Cody S Nelson, Kristy M Bialas, et al.
Hypertension (Dallas, Tex. : 1979)|February 12, 2016
Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention TrialTara I Chang, Gregory Evans, Alfred K Cheung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2015
Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell TransplantationZachary B Davis, Sarah A Cooley, Frank Cichocki, et al.
Pageof 57

Showing results (541-550 of 562) with videos related to

Sort By:
Pageof 57
The Lancet. Haematology|February 9, 2016
Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trialRyotaro Nakamura, Corinna La Rosa, Jeffrey Longmate, et al.
The Journal of Infectious Diseases|March 10, 2012
Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvantCorinna La Rosa, Jeff Longmate, Simon F Lacey, et al.
JAMA|October 10, 2023
A Multilevel Primary Care Intervention to Improve Follow-Up of Overdue Abnormal Cancer Screening Test Results: A Cluster Randomized Clinical TrialSteven J Atlas, Anna N A Tosteson, Adam Wright, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human PrimatesFlavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
Blood|July 2, 2011
Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic miceSimon F Lacey, Corinna La Rosa, Teodora Kaltcheva, et al.
NPJ Vaccines|January 22, 2022
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primatesFlavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
Blood Advances|January 10, 2022
Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunityHoda Pourhassan, Corinna La Rosa, Flavia Chiuppesi, et al.
Clinical and Vaccine Immunology : CVI|March 17, 2017
Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV TransmissionQihua Fan, Cody S Nelson, Kristy M Bialas, et al.
Hypertension (Dallas, Tex. : 1979)|February 12, 2016
Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention TrialTara I Chang, Gregory Evans, Alfred K Cheung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2015
Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell TransplantationZachary B Davis, Sarah A Cooley, Frank Cichocki, et al.
Pageof 57